Literature DB >> 8640227

Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse.

K J Lei1, H Chen, C J Pan, J M Ward, B Mosinger, E J Lee, H Westphal, B C Mansfield, J Y Chou.   

Abstract

Glycogen storage disease type 1a (GSD-1a) is caused by a deficiency in microsomal glucose-6-phosphatase (G6Pase), the key enzyme in glucose homeostasis. A G6Pase knockout mouse which mimics the pathophysiology of human GSD-1a patients was created to understand the pathogenesis of this disorder, to delineate the mechanisms of G6Pase catalysis, and to develop future therapeutic approaches. By examining G6Pase in the liver and kidney, the primary gluconeogenic tissues, we demonstrate that glucose-6-P transport and hydrolysis are performed by separate proteins which are tightly coupled. We propose a modified translocase catalytic unit model for G6Pase catalysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640227     DOI: 10.1038/ng0696-203

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  78 in total

1.  Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism.

Authors:  P She; M Shiota; K D Shelton; R Chalkley; C Postic; M A Magnuson
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice.

Authors:  Andrew I Su; Luca G Guidotti; John Paul Pezacki; Francis V Chisari; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

3.  In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA.

Authors:  Dustin J Landau; Elizabeth Drake Brooks; Pablo Perez-Pinera; Hiruni Amarasekara; Adam Mefferd; Songtao Li; Andrew Bird; Charles A Gersbach; Dwight D Koeberl
Journal:  Mol Ther       Date:  2016-02-11       Impact factor: 11.454

4.  In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.

Authors:  Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

Review 5.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

Review 6.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

Review 7.  The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Authors:  Romana Stark; Richard G Kibbey
Journal:  Biochim Biophys Acta       Date:  2013-10-28

8.  Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.

Authors:  Young Mok Lee; Hyun Sik Jun; Chi-Jiunn Pan; Su Ru Lin; Lane H Wilson; Brian C Mansfield; Janice Y Chou
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

9.  The gene for glycogen-storage disease type 1b maps to chromosome 11q23.

Authors:  B Annabi; H Hiraiwa; B C Mansfield; K J Lei; T Ubagai; M H Polymeropoulos; S W Moses; R Parvari; E Hershkovitz; H Mandel; M Fryman; J Y Chou
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

10.  Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

Authors:  Jun-Ho Cho; Goo-Young Kim; Brian C Mansfield; Janice Y Chou
Journal:  Biochem Biophys Res Commun       Date:  2018-03-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.